Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
QSAM Biosciences, Inc. | Director | COMMON STOCK | 400K | $1.2M | $3.00 | Dec 15, 2021 | Direct |
CITIUS ONCOLOGY, INC. | Director | Stock Option (Right to Buy) | 250K | Dec 12, 2024 | Direct | ||
QSAM Biosciences, Inc. | Director | Options to buy common stock | 54K | Aug 24, 2021 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
CTOR | CITIUS ONCOLOGY, INC. | Dec 12, 2024 | 1 | $0 | 4 | Dec 16, 2024 | Director |
TENK | TenX Keane Acquisition | Oct 13, 2022 | 0 | $0 | 3 | Oct 13, 2022 | Director |
QSAM | QSAM Biosciences, Inc. | Dec 31, 2021 | 2 | $0 | 5 | Feb 14, 2022 | Director |